vimarsana.com
Home
Live Updates
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China : vimarsana.com
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China : vimarsana.com
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China
/PRNewswire/ -- Jacobio Pharma (1167.HK) has received the Investigational New Drug (the "IND") approval of the combination therapy of KRAS G12C inhibitor...
Related Keywords
China ,
Beijing ,
Boston ,
Massachusetts ,
United States ,
Shanghai ,
Jacobio Pharma ,
Investigational New Drug ,
Drug Evaluation ,